103
Participants
Start Date
February 28, 2022
Primary Completion Date
June 5, 2024
Study Completion Date
June 5, 2024
Piqray Prescriber's/HCP guide for hyperglycemia
oncologists/healthcare professionals (HCPs) prescribing Piqray in the EU/EEA were provided with the Piqray Prescriber's/HCP Guide for hyperglycemia (educational material). The educational material aimed to provide oncologists/HCPs prescribing Piqray with additional measures/guidance prior to, and during treatment with Piqray for the identification and management of hyperglycemia.
Novartis Investigative Site, Basel
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY